spacer
home > ict > spring 2018 > perfecting performance
PUBLICATIONS
International Clinical Trials

Perfecting Performance

The integration of the new ICH E6 (R2) guideline has created many contradictory opinions about what is necessary to be implemented as sponsor oversight in clinical trials to fulfil its requirements. Of course, sponsor oversight in general is not new, but the details to perform mandatory oversight activities and manage compliance for all clinical trial activities are still raising discussions with different opinions and solutions.

Smaller sponsor, biopharmaceutical, and medical device companies moving into early phase clinical trials are especially struggling with the definition and integration of effective study oversight to manage the quality of their research.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gabriele Faist has more than 28 years' pharma industry experience, with 25 years working in CROs. At the CRO, she was responsible for overseeing clinical drug development programmes, which included line management of a group made up of more than 20, including Project Leaders, Senior Project Leaders, and even Project Assistants, as well as project-related leadership of worldwide multi-functional teams to effectively implement projects, tracking the programme progress to ensure that they are being completed on time and within budget, and maintaining the quality of all work within them.

Heike Schön has more than 25 years of experience in leadership positions in international clinical research and drug development in CROs and biotechnology companies. She has a profound knowledge of clinical drug development processes and regulatory requirements from first-in-human trials to market access. As General Manager, she gained experience in leading and developing a CRO and has successfully implemented her own company, LUMIS International, as Co-Founder and Managing Director. One of her main activities is to support small biotech companies in setting up their clinical
spacer
Gabriele Faist
spacer
spacer
spacer
Heike Schön
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers
 
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement